Evidence map›Paper›PMID 42237246›Full record

ArticleBMC plant biology2026

Facile synthesis of ZnO/Biochar Nanocomposites (ZBNcs) and investigation of their nano-priming effects on reducing the accumulation of arsenic (As) in Triticum aestivum cv. Azar-2.

Zahra Souri, Naser Karimi, Elahe Ghanbari, Leila Norouzi, Abbu Zaid

Abstract read
In one paragraph

Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zahra SouriDepartment of Biology, Faculty of Science, Razi University, Kermanshah, Iran.
Naser KarimiDepartment of Biology, Faculty of Science, Razi University, Kermanshah, Iran. nkarimi@razi.ac.ir.
Elahe GhanbariDepartment of Biology, Faculty of Science, Razi University, Kermanshah, Iran.
Leila NorouziResearch Center for Environmental Determinants of Health, Health Institute, University of Medical Sciences, Kermanshah, Iran.
Abbu ZaidDepartment of Botany, Government Degree College Kathua, Kathua, Jammu, Kashmir, 184104, India.ORCID http://orcid.org/0000-0002-2090-0212

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe main purpose of this study is to investigate the priming effect of ZnO/biochar nanocomposites (ZBNCs) in mitigating arsenic (As) toxicity in wheat plants. The research question focuses on how ZBNCs can reverse the adverse effects of As stress on plant growth and physiological functions. ZBNCs were synthesized via a one-step carbonization process using grape leaf waste. Characterization of the nanoparticles was performed using SEM, FT-IR spectroscopy, and XRD analysis. The synthesized nanoparticles (NPs) were then used for seed priming at concentrations of 0, 25, 50, and 75 mg/L to assess their effects on wheat plants exposed to As at concentrations of 0, 25, 50, and 100 mg/L.

resultsAs stress impaired wheat growth and physiological parameters in a dose-dependent manner. However, seed priming with ZBNCs reversed growth inhibition, reduced H₂O₂ content and shoot As accumulation, and enhanced POD and GST activities, indicating that ZBNCs mitigate As toxicity primarily through enzymatic antioxidant enhancement and reduced oxidative stress.

conclusionThis study demonstrates the potential of ZBNCs for mitigating As stress in wheat under greenhouse conditions, suggesting their promise for sustainable crop production in As-affected regions.

Indexed as

ArsenicNanocompositesTriticumZinc OxideAntioxidantsOxidative StressSeedsAntioxidantsArsenicZinc OxideMetalloidNanoparticlesPrimingWheat

Identifiers

PMID42237246
PMCPMC13449465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.